Trade Qiagen NV - QIA CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.130 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.022046% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | -0.000176% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | EUR | ||||||||
Margin | 5% | ||||||||
Stock exchange | Germany | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Qiagen NV ESG Risk Ratings
‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly
Prev. Close* | 37.655 |
Open* | 37.655 |
1-Year Change* | -20.38% |
Day's Range* | 37.425 - 37.945 |
52 wk Range | 34.74-51.18 |
Average Volume (10 days) | 1.07M |
Average Volume (3 months) | 27.05M |
Market Cap | 9.21B |
P/E Ratio | 27.98 |
Shares Outstanding | 228.18M |
Revenue | 1.95B |
EPS | 1.44 |
Dividend (Yield %) | N/A |
Beta | 0.42 |
Next Earnings Date | Feb 5, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 1, 2023 | 37.945 | 0.510 | 1.36% | 37.435 | 37.955 | 37.405 |
Nov 30, 2023 | 37.655 | 0.420 | 1.13% | 37.235 | 37.705 | 37.235 |
Nov 29, 2023 | 37.575 | 0.450 | 1.21% | 37.125 | 37.765 | 37.055 |
Nov 28, 2023 | 37.065 | 0.190 | 0.52% | 36.875 | 37.215 | 36.755 |
Nov 27, 2023 | 37.155 | 0.080 | 0.22% | 37.075 | 37.655 | 37.075 |
Nov 24, 2023 | 37.245 | -0.120 | -0.32% | 37.365 | 37.605 | 37.125 |
Nov 23, 2023 | 37.465 | 0.120 | 0.32% | 37.345 | 37.535 | 37.035 |
Nov 22, 2023 | 37.525 | 0.570 | 1.54% | 36.955 | 37.595 | 36.915 |
Nov 21, 2023 | 36.865 | 0.785 | 2.18% | 36.080 | 36.895 | 36.080 |
Nov 20, 2023 | 36.110 | -0.010 | -0.03% | 36.120 | 36.485 | 36.020 |
Nov 17, 2023 | 36.110 | 0.035 | 0.10% | 36.075 | 36.595 | 36.075 |
Nov 16, 2023 | 36.270 | 0.220 | 0.61% | 36.050 | 36.425 | 36.050 |
Nov 15, 2023 | 36.455 | 0.170 | 0.47% | 36.285 | 36.855 | 36.010 |
Nov 14, 2023 | 36.365 | 0.615 | 1.72% | 35.750 | 36.685 | 35.750 |
Nov 13, 2023 | 35.790 | 0.380 | 1.07% | 35.410 | 35.840 | 35.310 |
Nov 10, 2023 | 35.140 | -0.260 | -0.73% | 35.400 | 35.690 | 35.020 |
Nov 9, 2023 | 35.910 | -0.110 | -0.31% | 36.020 | 36.395 | 35.840 |
Nov 8, 2023 | 36.305 | 0.020 | 0.06% | 36.285 | 36.695 | 36.285 |
Nov 7, 2023 | 36.485 | 0.575 | 1.60% | 35.910 | 36.655 | 35.890 |
Nov 6, 2023 | 36.260 | -0.165 | -0.45% | 36.425 | 36.595 | 36.210 |
Qiagen NV Events
Time (UTC) | Country | Event |
---|---|---|
Tuesday, December 12, 2023 | ||
Time (UTC) 13:00 | Country NL
| Event Qiagen NV at Exane BNPP Diagnostics, Imaging & Life Sciences CEO Conference (Virtual) Qiagen NV at Exane BNPP Diagnostics, Imaging & Life Sciences CEO Conference (Virtual)Forecast -Previous - |
Monday, February 5, 2024 | ||
Time (UTC) 21:05 | Country NL
| Event Q4 2023 Qiagen NV Earnings Release Q4 2023 Qiagen NV Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 2141.52 | 2251.66 | 1870.35 | 1526.42 | 1501.85 |
Revenue | 2141.52 | 2251.66 | 1870.35 | 1526.42 | 1501.85 |
Cost of Revenue, Total | 756.955 | 800.837 | 637.631 | 521.162 | 499.271 |
Gross Profit | 1384.56 | 1450.82 | 1232.71 | 1005.26 | 1002.58 |
Total Operating Expense | 1610.06 | 1621.57 | 1483.92 | 1547.76 | 1235.27 |
Selling/General/Admin. Expenses, Total | 603.945 | 584.468 | 525.362 | 505.268 | 508.146 |
Research & Development | 189.859 | 189.964 | 149.072 | 157.448 | 161.852 |
Depreciation / Amortization | 14.531 | 18.542 | 20.811 | 29.973 | 39.032 |
Unusual Expense (Income) | 44.768 | 27.762 | 151.039 | 333.91 | 26.966 |
Operating Income | 531.46 | 630.084 | 386.431 | -21.337 | 266.581 |
Interest Income (Expense), Net Non-Operating | -19.1 | -5.122 | -59.918 | -43.696 | -70.168 |
Other, Net | 0.241 | 0.871 | 112.959 | -12.743 | 29.324 |
Net Income Before Taxes | 512.601 | 625.833 | 439.472 | -77.776 | 225.737 |
Net Income After Taxes | 423.211 | 512.599 | 359.188 | -41.455 | 190.38 |
Minority Interest | 0 | ||||
Net Income Before Extra. Items | 423.211 | 512.599 | 359.188 | -41.455 | 190.38 |
Net Income | 423.211 | 512.599 | 359.188 | -41.455 | 190.38 |
Income Available to Common Excl. Extra. Items | 423.211 | 512.599 | 359.188 | -41.455 | 190.38 |
Income Available to Common Incl. Extra. Items | 423.211 | 512.599 | 359.188 | -41.455 | 190.38 |
Dilution Adjustment | 0 | ||||
Diluted Net Income | 423.211 | 512.599 | 359.188 | -41.455 | 190.38 |
Diluted Weighted Average Shares | 230.136 | 232.034 | 234.214 | 226.777 | 233.456 |
Diluted EPS Excluding Extraordinary Items | 1.83896 | 2.20915 | 1.53359 | -0.1828 | 0.81549 |
Diluted Normalized EPS | 1.99957 | 2.30715 | 2.00343 | 0.77427 | 0.9129 |
Total Extraordinary Items |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 494.857 | 485.398 | 497.984 | 499.631 | 515.512 |
Revenue | 494.857 | 485.398 | 497.984 | 499.631 | 515.512 |
Cost of Revenue, Total | 182.705 | 177.922 | 180.46 | 178.58 | 184.494 |
Gross Profit | 312.152 | 307.476 | 317.524 | 321.051 | 331.018 |
Total Operating Expense | 389.425 | 388.688 | 393.411 | 401.972 | 393.355 |
Selling/General/Admin. Expenses, Total | 145.523 | 147.58 | 154.211 | 145.462 | 151.418 |
Research & Development | 49.893 | 54.718 | 44.719 | 48.868 | 49.896 |
Depreciation / Amortization | 2.702 | 2.657 | 5.969 | 2.846 | 2.799 |
Unusual Expense (Income) | 8.602 | 5.811 | 8.052 | 26.216 | 4.748 |
Operating Income | 105.432 | 96.71 | 104.573 | 97.659 | 122.157 |
Interest Income (Expense), Net Non-Operating | -3.054 | 11.954 | 1.387 | -2.452 | -6.521 |
Other, Net | -0.062 | 0.123 | -0.123 | 0.511 | -0.112 |
Net Income Before Taxes | 102.316 | 108.787 | 105.837 | 95.718 | 115.524 |
Net Income After Taxes | 80.786 | 85.035 | 88.844 | 82.394 | 96.661 |
Net Income Before Extra. Items | 80.786 | 85.035 | 88.844 | 82.394 | 96.661 |
Net Income | 80.786 | 85.035 | 88.844 | 82.394 | 96.661 |
Income Available to Common Excl. Extra. Items | 80.786 | 85.035 | 88.844 | 82.394 | 96.661 |
Income Available to Common Incl. Extra. Items | 80.786 | 85.035 | 88.844 | 82.394 | 96.661 |
Diluted Net Income | 80.786 | 85.035 | 88.844 | 82.394 | 96.661 |
Diluted Weighted Average Shares | 230.517 | 230.602 | 230.358 | 230.084 | 229.938 |
Diluted EPS Excluding Extraordinary Items | 0.35046 | 0.36875 | 0.38568 | 0.3581 | 0.42038 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | 0.37992 | 0.38845 | 0.41502 | 0.45618 | 0.43766 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 2393.95 | 2109.6 | 1624.41 | 1570.25 | 2155.06 |
Cash and Short Term Investments | 1418.27 | 1065.3 | 715.233 | 753.233 | 1393.69 |
Cash | 122.314 | 235.381 | 245.373 | 189.569 | 208.083 |
Short Term Investments | 687.597 | 184.785 | 117.249 | 563.664 | 1185.6 |
Total Receivables, Net | 434.068 | 469.663 | 486.605 | 484.608 | 422.091 |
Accounts Receivable - Trade, Net | 333.518 | 376.213 | 389.058 | 385.117 | 351.612 |
Total Inventory | 357.96 | 327.525 | 291.181 | 170.704 | 162.912 |
Prepaid Expenses | 50.958 | 60.629 | 61.159 | 45.409 | 48.25 |
Other Current Assets, Total | 132.7 | 186.484 | 70.227 | 116.294 | 128.122 |
Total Assets | 6287.73 | 6146.95 | 5869.62 | 5235.62 | 5748.33 |
Property/Plant/Equipment, Total - Net | 757.693 | 739.077 | 661.894 | 455.243 | 511.659 |
Property/Plant/Equipment, Total - Gross | 1260.66 | 1371.49 | 1292.34 | 1154.37 | 1115.09 |
Accumulated Depreciation, Total | -502.967 | -632.416 | -630.443 | -699.13 | -603.43 |
Goodwill, Net | 2352.57 | 2350.76 | 2364.03 | 2140.5 | 2108.54 |
Intangibles, Net | 544.796 | 627.436 | 726.194 | 632.434 | 475.043 |
Other Long Term Assets, Total | 215.225 | 294.676 | 488.995 | 356.488 | 437.434 |
Total Current Liabilities | 974.523 | 1517.47 | 572.175 | 951.345 | 972.189 |
Accounts Payable | 98.734 | 101.224 | 118.153 | 84.767 | 69.415 |
Accrued Expenses | 215.702 | 219.936 | 220.755 | 332.151 | 209.748 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 389.552 | 847.626 | 42.539 | 285.244 | 503.177 |
Other Current Liabilities, Total | 270.535 | 348.684 | 190.728 | 249.183 | 189.849 |
Total Liabilities | 2821.12 | 3050.4 | 3071.78 | 2699.02 | 3113.36 |
Total Long Term Debt | 1471.9 | 1094.14 | 1880.21 | 1421.11 | 1671.09 |
Long Term Debt | 1471.9 | 1094.14 | 1880.21 | 1421.11 | 1671.09 |
Deferred Income Tax | 17.5 | 37.591 | 39.216 | 23.442 | 63.411 |
Minority Interest | |||||
Other Liabilities, Total | 357.203 | 401.199 | 580.179 | 303.13 | 406.672 |
Total Equity | 3466.61 | 3096.55 | 2797.84 | 2536.59 | 2634.97 |
Common Stock | 2.702 | 2.702 | 2.702 | 2.702 | 2.702 |
Additional Paid-In Capital | 1868.02 | 1818.51 | 1834.17 | 1777.02 | 1742.19 |
Retained Earnings (Accumulated Deficit) | 2160.17 | 1791.74 | 1323.09 | 1178.46 | 1379.62 |
Treasury Stock - Common | -160.188 | -189.73 | -118.301 | -111.966 | -178.903 |
Unrealized Gain (Loss) | 0 | ||||
Other Equity, Total | -404.091 | -326.67 | -243.822 | -309.619 | -310.644 |
Total Liabilities & Shareholders’ Equity | 6287.73 | 6146.95 | 5869.62 | 5235.62 | 5748.33 |
Total Common Shares Outstanding | 227.716 | 227.074 | 227.985 | 227.752 | 225.509 |
Long Term Investments | 23.5 | 25.4 | 4.1 | 80.7 | 60.6 |
Note Receivable - Long Term | |||||
Cash & Equivalents | 608.355 | 645.135 | 352.611 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Total Current Assets | 1962.39 | 2311.43 | 2251.32 | 2393.95 | 2755.51 |
Cash and Short Term Investments | 1015.78 | 1331.9 | 1287.34 | 1418.27 | 1886.98 |
Cash & Equivalents | 579.935 | 609.549 | 359.18 | 730.669 | 1271.6 |
Short Term Investments | 435.843 | 722.352 | 928.161 | 687.597 | 615.387 |
Total Receivables, Net | 326.69 | 327.899 | 329.544 | 333.518 | 323.175 |
Accounts Receivable - Trade, Net | 326.69 | 327.899 | 329.544 | 333.518 | 323.175 |
Total Inventory | 399.207 | 391.989 | 380.824 | 357.96 | 323.472 |
Prepaid Expenses | 220.715 | 259.639 | 253.609 | 284.208 | 221.882 |
Total Assets | 5906.7 | 6347.27 | 6278.95 | 6287.73 | 6516.62 |
Property/Plant/Equipment, Total - Net | 706.02 | 706.84 | 691.055 | 662.17 | 590.983 |
Property/Plant/Equipment, Total - Gross | 1252.48 | 1222.98 | 1165.14 | 1075.87 | |
Accumulated Depreciation, Total | -545.641 | -531.924 | -502.967 | -484.887 | |
Goodwill, Net | 2434.47 | 2456.54 | 2454.08 | 2352.57 | 2299.26 |
Intangibles, Net | 542.604 | 570.192 | 585.021 | 544.796 | 551.587 |
Long Term Investments | 27.3 | 27.7 | 23.5 | 21 | |
Other Long Term Assets, Total | 261.217 | 274.97 | 269.778 | 310.748 | 298.273 |
Total Current Liabilities | 524.371 | 978.45 | 890.244 | 974.523 | 1497.54 |
Accounts Payable | 76.887 | 83.939 | 84.386 | 98.734 | 82.836 |
Accrued Expenses | 346.876 | 325.962 | 341.615 | 417.237 | 487.562 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | |
Current Port. of LT Debt/Capital Leases | 100.608 | 500.149 | 393.243 | 389.552 | 866.04 |
Other Current Liabilities, Total | 68.4 | 71 | 69 | 61.1 | |
Total Liabilities | 2213 | 2723.66 | 2717.78 | 2821.12 | 3188.86 |
Total Long Term Debt | 1382.36 | 1387.94 | 1486.71 | 1471.9 | 1423.21 |
Long Term Debt | 1382.36 | 1387.94 | 1486.71 | 1471.9 | 1423.21 |
Deferred Income Tax | 17.5 | 9.387 | |||
Other Liabilities, Total | 306.268 | 357.273 | 340.827 | 357.203 | 258.726 |
Total Equity | 3693.7 | 3623.61 | 3561.18 | 3466.61 | 3327.76 |
Common Stock | 2.702 | 2.702 | 2.702 | 2.702 | 2.702 |
Additional Paid-In Capital | 1903.08 | 1890.02 | 1882.16 | 1868.02 | 1854.36 |
Retained Earnings (Accumulated Deficit) | 2360.88 | 2283.06 | 2215.43 | 2160.17 | 2072.57 |
Treasury Stock - Common | -134.277 | -134.277 | -142.855 | -160.188 | -160.943 |
Other Equity, Total | -438.687 | -417.902 | -396.261 | -404.091 | -440.933 |
Total Liabilities & Shareholders’ Equity | 5906.7 | 6347.27 | 6278.95 | 6287.73 | 6516.62 |
Total Common Shares Outstanding | 228.182 | 228.182 | 228.035 | 227.716 | 227.7 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | 423.211 | 512.599 | 359.188 | -41.455 | 190.38 |
Cash From Operating Activities | 715.264 | 639.001 | 457.806 | 330.843 | 359.496 |
Cash From Operating Activities | 208.397 | 214.931 | 205.014 | 231.458 | 206.436 |
Deferred Taxes | -9.603 | -5.288 | -6.706 | -55.362 | -23.272 |
Non-Cash Items | 125.14 | 46.771 | -27.423 | 240.526 | 81.111 |
Cash Taxes Paid | 98.565 | 102.083 | 42.572 | 41.474 | 29.317 |
Cash Interest Paid | 23.208 | 21.588 | 25.351 | 29.721 | 25.902 |
Changes in Working Capital | -31.881 | -130.012 | -72.267 | -44.324 | -95.159 |
Cash From Investing Activities | -726.763 | -202.426 | -443.281 | -222.278 | -211.356 |
Capital Expenditures | -149.336 | -206.534 | -304.237 | -274.884 | -150.763 |
Other Investing Cash Flow Items, Total | -577.427 | 4.108 | -139.044 | 52.606 | -60.593 |
Cash From Financing Activities | -125.803 | -150.366 | -50.127 | -639.08 | 360.408 |
Financing Cash Flow Items | -17.373 | -16.953 | -23.451 | -61.279 | -8.019 |
Issuance (Retirement) of Stock, Net | 0.121 | -92.068 | 8.876 | 62.362 | -27.867 |
Issuance (Retirement) of Debt, Net | -108.551 | -41.345 | -35.552 | -640.163 | 396.294 |
Foreign Exchange Effects | -12.545 | -3.677 | 4.196 | 0.826 | -7.183 |
Net Change in Cash | -149.847 | 282.532 | -31.406 | -529.689 | 501.365 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 85.035 | 423.211 | 334.367 | 251.973 | 155.312 |
Cash From Operating Activities | 71.926 | 715.264 | 590.945 | 379.363 | 207.41 |
Cash From Operating Activities | 52.061 | 208.397 | 153.725 | 103.408 | 52.998 |
Deferred Taxes | -4.341 | -9.603 | -40.196 | -3.95 | 0.615 |
Non-Cash Items | 13.323 | 125.14 | 95.413 | 47.519 | 21.86 |
Changes in Working Capital | -74.152 | -31.881 | 47.636 | -19.587 | -23.375 |
Cash From Investing Activities | -433.847 | -726.763 | -602.237 | -557.789 | -306.252 |
Capital Expenditures | -38.409 | -149.336 | -102.745 | -76.024 | -38.415 |
Other Investing Cash Flow Items, Total | -395.438 | -577.427 | -499.492 | -481.765 | -267.837 |
Cash From Financing Activities | -9.828 | -125.803 | 420.57 | 12.549 | -10.658 |
Financing Cash Flow Items | -9.903 | -17.373 | 49.011 | 12.443 | -10.687 |
Issuance (Retirement) of Stock, Net | 0.075 | 0.121 | 0.107 | 0.106 | 0.029 |
Issuance (Retirement) of Debt, Net | -108.551 | 371.452 | 0 | 0 | |
Foreign Exchange Effects | 0.26 | -12.545 | -18.197 | -8.105 | -0.501 |
Net Change in Cash | -371.489 | -149.847 | 391.081 | -173.982 | -110.001 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
MFS Investment Management | Investment Advisor/Hedge Fund | 8.7992 | 20078128 | -102677 | 2023-06-30 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.722 | 8492990 | 141460 | 2023-06-30 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 3.0334 | 6921770 | 10881 | 2023-05-09 | LOW |
Amundi Asset Management, SAS | Investment Advisor/Hedge Fund | 1.9838 | 4526635 | 1663553 | 2023-06-30 | LOW |
Fidelity International | Investment Advisor | 1.9505 | 4450800 | 1412750 | 2023-06-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.9066 | 4350561 | -90657 | 2023-06-30 | LOW |
UBS Asset Management (Switzerland) | Investment Advisor | 1.8754 | 4279398 | 765282 | 2022-12-19 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 1.466 | 3345086 | 580634 | 2023-06-30 | LOW |
BlackRock Asset Management Deutschland AG | Investment Advisor | 1.4559 | 3322170 | 25311 | 2023-09-30 | LOW |
Deka Investment GmbH | Investment Advisor/Hedge Fund | 1.2493 | 2850742 | 388353 | 2023-06-30 | LOW |
Marshall Wace LLP | Investment Advisor/Hedge Fund | 1.163 | 2653783 | 522140 | 2023-06-30 | HIGH |
Schroder Investment Management Ltd. (SIM) | Investment Advisor/Hedge Fund | 1.1065 | 2524765 | -14911 | 2023-08-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.9641 | 2200010 | -25442 | 2023-06-30 | LOW |
Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.9014 | 2056848 | 327955 | 2023-06-30 | LOW |
Millennium Management LLC | Hedge Fund | 0.857 | 1955605 | 1619566 | 2023-06-30 | HIGH |
Morgan Stanley & Co. LLC | Research Firm | 0.8515 | 1943006 | -12785 | 2023-06-30 | MED |
BofA Global Research (US) | Research Firm | 0.8364 | 1908531 | -182510 | 2023-06-30 | LOW |
HSBC Global Asset Management (UK) Limited | Investment Advisor/Hedge Fund | 0.8349 | 1905156 | -72184 | 2023-06-30 | LOW |
PRIMECAP Management Company | Investment Advisor | 0.8182 | 1867017 | -3540 | 2023-06-30 | |
Nekton Capital Limited | Hedge Fund | 0.7597 | 1733397 | -49500 | 2023-06-30 | HIGH |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Qiagen Company profile
About Qiagen NV
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Qiagen NV revenues increased 20% to $2.25B. Net income increased 43% to $512.6M. Revenues reflect Consumables and Related Revenues segment increase of 23% to $1.99B, Instrumentation segment increase of 4% to $265.3M, United States segment increase of 25% to $909.7M, Europe & Middle East & Afric segment increase of 19% to $814.4M. Net income benefited from Restructuring decrease of 81% to $27.8M (expense).
Equity composition
1/2017, Shares Consolidation (Factor: 0.96296).
Industry: | Biotechnology & Medical Research (NEC) |
Hulsterweg 82
VENLO
LIMBURG 5912 PL
NL
Income Statement
- Annual
- Quarterly
News

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
12:39, 30 November 2023
Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023
UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?
UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.
10:48, 21 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com